trending Market Intelligence /marketintelligence/en/news-insights/trending/LeI4GjWza32zgHeNXnQtTQ2 content esgSubNav
In This List

Editas Medicine appoints CEO

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Editas Medicine appoints CEO

Editas Medicine Inc.'s board appointed Cynthia Collins as the company's president and CEO.

Collins was serving as the genome-editing company's interim CEO since March 1.

Prior to joining Massachusets-based Editas Medicine, Collins was the CEO of Human Longevity Inc., which is building a database on human genotypes and phenotypes and using machine learning to help develop new medicines.

Collins is also a member of the board for the ARM Foundation for Cell and Gene Medicine, Triumvira Immunologics Inc., DermTech Inc. and Biocare Medical LLC.